Ijichi H - Search Results

1

Efficacy of Adjuvant Combination Therapy With Trastuzumab and Chemotherapy in HER2-positive Early Breast Cancer: A Single Institutional Cohort Study from Clinical Practice.

Okamoto M, Tajiri W, Ueo H, Masuda T, Ijichi H, Koga C, Nakamura Y, Taguchi K, Ohno S, Tokunaga E. Okamoto M, et al. Among authors: ijichi h. Anticancer Res. 2020 Jun;40(6):3315-3323. doi: 10.21873/anticanres.14314. Anticancer Res. 2020. PMID: 32487627

2

Impact of Visceral Metastasis on Efficacy of Fulvestrant in Patients with Hormone Receptor-positive Recurrent Breast Cancer.

Koi Y, Koga C, Akiyoshi S, Masuda T, Ijichi H, Nakamura Y, Ishida M, Ohno S, Tokunaga E. Koi Y, et al. Among authors: ijichi h. Anticancer Res. 2018 Mar;38(3):1579-1584. doi: 10.21873/anticanres.12387. Anticancer Res. 2018. PMID: 29491088

3

CD44v9 as a poor prognostic factor of triple-negative breast cancer treated with neoadjuvant chemotherapy.

Tokunaga E, Fujita A, Takizawa K, Baba K, Akiyoshi S, Nakamura Y, Ijichi H, Masuda T, Koga C, Tajiri W, Ohno S, Taguchi K, Ishida M. Tokunaga E, et al. Among authors: ijichi h. Breast Cancer. 2019 Jan;26(1):47-57. doi: 10.1007/s12282-018-0888-y. Epub 2018 Jul 3. Breast Cancer. 2019. PMID: 29971631 Free PMC article.

4

The comparison of the anatomic stage and pathological prognostic stage according to the AJCC 8th edition for the prognosis in Japanese breast cancer patients: data from a single institution.

Tokunaga E, Ijichi H, Tajiri W, Masuda T, Takizawa K, Ueo H, Koga C, Tanaka J, Nakamura Y, Ohno S, Taguchi K, Okamoto M. Tokunaga E, et al. Among authors: ijichi h. Breast Cancer. 2020 Nov;27(6):1137-1146. doi: 10.1007/s12282-020-01116-w. Epub 2020 May 29. Breast Cancer. 2020. PMID: 32472474 Free PMC article.

5

The clinical usefulness of the CTS5 in the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancer.

Tajiri W, Ijichi H, Takizawa K, Koi Y, Masuda T, Ueo H, Koga C, Nakamura Y, Taguchi K, Okamoto M, Tokunaga E. Tajiri W, et al. Among authors: ijichi h. Breast Cancer. 2021 Jan;28(1):67-74. doi: 10.1007/s12282-020-01130-y. Epub 2020 Jun 29. Breast Cancer. 2021. PMID: 32601800 Free PMC article.

6

Impact of serum vitamin D on the response and prognosis in breast cancer patients treated with neoadjuvant chemotherapy.

Tokunaga E, Masuda T, Ijichi H, Tajiri W, Koga C, Koi Y, Nakamura Y, Ohno S, Taguchi K, Okamoto M. Tokunaga E, et al. Among authors: ijichi h. Breast Cancer. 2022 Jan;29(1):156-163. doi: 10.1007/s12282-021-01292-3. Epub 2021 Sep 6. Breast Cancer. 2022. PMID: 34487328 Free PMC article.

7

Successful Prevention of Tumour Lysis Syndrome in HER2-positive Breast Cancer: Case Report and Literature Review.

Omori S, Shigechi T, Kawaguchi K, Ijichi H, Oki E, Yoshizumi T. Omori S, et al. Among authors: ijichi h. Anticancer Res. 2023 May;43(5):2371-2377. doi: 10.21873/anticanres.16403. Anticancer Res. 2023. PMID: 37097695 Review.

8

Prognostic criteria in colorectal carcinoma constructed by the combination of tumor-related and host-related factors.

Nozoe T, Matono R, Ijichi H, Ohga T, Ezaki T. Nozoe T, et al. Among authors: ijichi h. Am J Surg. 2014 Jul;208(1):119-23. doi: 10.1016/j.amjsurg.2013.08.043. Epub 2014 Jan 3. Am J Surg. 2014. PMID: 24612685

9

Risk factors that increase mortality after living donor liver transplantation.

Yoshizumi T, Shirabe K, Taketomi A, Uchiyama H, Harada N, Ijichi H, Yoshimatsu M, Ikegami T, Soejima Y, Maehara Y. Yoshizumi T, et al. Among authors: ijichi h. Transplantation. 2012 Jan 15;93(1):93-8. doi: 10.1097/TP.0b013e318238dacd. Transplantation. 2012. PMID: 22203391

10

Acoustic radiation force impulse imaging predicts postoperative ascites resulting from curative hepatic resection for hepatocellular carcinoma.

Harada N, Shirabe K, Ijichi H, Matono R, Uchiyama H, Yoshizumi T, Taketomi A, Soejima Y, Maehara Y. Harada N, et al. Among authors: ijichi h. Surgery. 2012 Jun;151(6):837-43. doi: 10.1016/j.surg.2011.12.035. Epub 2012 Mar 3. Surgery. 2012. PMID: 22386275

11

Technical evolution of laparoscopic hepatic resection: a single institutional experience.

Soejima Y, Ikegami T, Ijichi H, Ikeda T, Shirabe K, Yoshizumi T, Uchiyama H, Yamashita Y, Harimoto N, Toshima T, Matsuura H, Okadome K, Maehara Y. Soejima Y, et al. Among authors: ijichi h. Fukuoka Igaku Zasshi. 2012 Nov;103(11):226-32. Fukuoka Igaku Zasshi. 2012. PMID: 23397877 Free article.

12

Glasgow Prognostic Score (GPS) can be a useful indicator to determine prognosis of patients with colorectal carcinoma.

Nozoe T, Matono R, Ijichi H, Ohga T, Ezaki T. Nozoe T, et al. Among authors: ijichi h. Int Surg. 2014 Sep-Oct;99(5):512-7. doi: 10.9738/INTSURG-D-13-00118.1. Int Surg. 2014. PMID: 25216413 Free PMC article.

13

Deceleration of regenerative response improves the outcome of rat with massive hepatectomy.

Ninomiya M, Shirabe K, Terashi T, Ijichi H, Yonemura Y, Harada N, Soejima Y, Taketomi A, Shimada M, Maehara Y. Ninomiya M, et al. Among authors: ijichi h. Am J Transplant. 2010 Jul;10(7):1580-7. doi: 10.1111/j.1600-6143.2010.03150.x. Am J Transplant. 2010. PMID: 20642684 Free article.

14

Feasibility of left lobe living donor liver transplantation between adults: an 8-year, single-center experience of 107 cases.

Soejima Y, Taketomi A, Yoshizumi T, Uchiyama H, Harada N, Ijichi H, Yonemura Y, Shimada M, Maehara Y. Soejima Y, et al. Among authors: ijichi h. Am J Transplant. 2006 May;6(5 Pt 1):1004-11. doi: 10.1111/j.1600-6143.2006.01284.x. Am J Transplant. 2006. PMID: 16611337 Free article.

15

Evaluation of graft stiffness using acoustic radiation force impulse imaging after living donor liver transplantation.

Ijichi H, Shirabe K, Matsumoto Y, Yoshizumi T, Ikegami T, Kayashima H, Morita K, Toshima T, Mano Y, Maehara Y. Ijichi H, et al. Clin Transplant. 2014 Nov;28(11):1256-62. doi: 10.1111/ctr.12457. Epub 2014 Oct 15. Clin Transplant. 2014. PMID: 25203425

16

Clinical usefulness of (18) F-fluorodeoxyglucose positron emission tomography/computed tomography for patients with primary liver cancer with special reference to rare histological types, hepatocellular carcinoma with sarcomatous change and combined hepatocellular and cholangiocarcinoma.

Ijichi H, Shirabe K, Taketomi A, Yoshizumi T, Ikegami T, Mano Y, Aishima S, Abe K, Honda H, Maehara Y. Ijichi H, et al. Hepatol Res. 2013 May;43(5):481-7. doi: 10.1111/j.1872-034X.2012.01107.x. Epub 2012 Nov 12. Hepatol Res. 2013. PMID: 23145869

17

Recurrent hepatitis B following recurrence of hepatocellular carcinoma after living donor liver transplantation.

Ijichi H, Yoshizumi T, Ikegami T, Soejima Y, Ikeda T, Kawanaka H, Uchiyama H, Yamashita Y, Morita M, Oki E, Mimori K, Sugimachi K, Saeki H, Watanabe M, Shirabe K, Maehara Y. Ijichi H, et al. Fukuoka Igaku Zasshi. 2013 Oct;104(10):376-82. Fukuoka Igaku Zasshi. 2013. PMID: 24511669 Free article.

18

[Living donor liver transplantation for a patient with renal failure].

Ijichi H, Shimada M, Suehiro T, Soejima Y, Maehara Y, Nakamuta M, Nawata H. Ijichi H, et al. Fukuoka Igaku Zasshi. 2002 Dec;93(12):266-71. Fukuoka Igaku Zasshi. 2002. PMID: 12632631 Japanese.

19

Sustained spatial disturbance of bile canalicular networks during regeneration of the steatotic rat liver.

Ninomiya M, Shimada M, Terashi T, Ijichi H, Yonemura Y, Harada N, Soejima Y, Suehiro T, Maehara Y. Ninomiya M, et al. Among authors: ijichi h. Transplantation. 2004 Feb 15;77(3):373-9. doi: 10.1097/01.TP.0000109777.51902.09. Transplantation. 2004. PMID: 14966410

20

The impact of splenectomy or splenic artery ligation on the outcome of a living donor adult liver transplantation using a left lobe graft.

Shimada M, Ijichi H, Yonemura Y, Harada N, Shiotani S, Ninomiya M, Terashi T, Yoshizumi T, Soejima Y, Suehiro T, Maehara Y. Shimada M, et al. Among authors: ijichi h. Hepatogastroenterology. 2004 May-Jun;51(57):625-9. Hepatogastroenterology. 2004. PMID: 15143878

21

Is graft size a major risk factor in living-donor adult liver transplantation?

Shimada M, Ijichi H, Yonemura Y, Harada N, Shiotani S, Ninomiya M, Yoshizumi T, Soejima Y, Suehiro T, Maehara Y. Shimada M, et al. Among authors: ijichi h. Transpl Int. 2004 Jul;17(6):310-6. doi: 10.1007/s00147-004-0720-9. Epub 2004 Jun 22. Transpl Int. 2004. PMID: 15221124 Free article.

22

Living donor liver transplantation for hepatocellular carcinoma: a special reference to a preoperative des-gamma-carboxy prothrombin value.

Shimada M, Yonemura Y, Ijichi H, Harada N, Shiotani S, Ninomiya M, Terashi T, Yoshizumi T, Soejima Y, Maehara Y. Shimada M, et al. Among authors: ijichi h. Transplant Proc. 2005 Mar;37(2):1177-9. doi: 10.1016/j.transproceed.2004.12.030. Transplant Proc. 2005. PMID: 15848661

23

Validity of preoperative volumetric analysis of congestion volume in living donor liver transplantation using three-dimensional computed tomography.

Yonemura Y, Taketomi A, Soejima Y, Yoshizumi T, Uchiyama H, Gion T, Harada N, Ijichi H, Yoshimitsu K, Maehara Y. Yonemura Y, et al. Among authors: ijichi h. Liver Transpl. 2005 Dec;11(12):1556-62. doi: 10.1002/lt.20537. Liver Transpl. 2005. PMID: 16315296 Free article.

24

Effect of hyperbaric oxygen on cold storage of the liver in rats.

Ijichi H, Taketomi A, Soejima Y, Yoshizumi T, Uchiyama H, Shimada M, Maehara Y. Ijichi H, et al. Liver Int. 2006 Mar;26(2):248-53. doi: 10.1111/j.1478-3231.2005.01218.x. Liver Int. 2006. PMID: 16448464

25

Successful adult-to-adult living donor liver transplantation in a patient with moderate to severe portopulmonary hypertension.

Uchiyama H, Soejima Y, Taketomi A, Yoshizumi T, Harada N, Ijichi H, Yonemura Y, Maehara Y. Uchiyama H, et al. Among authors: ijichi h. Liver Transpl. 2006 Mar;12(3):481-4. doi: 10.1002/lt.20691. Liver Transpl. 2006. PMID: 16498645 Free article.

26

Hyperbaric oxygen induces vascular endothelial growth factor and reduces liver injury in regenerating rat liver after partial hepatectomy.

Ijichi H, Taketomi A, Yoshizumi T, Uchiyama H, Yonemura Y, Soejima Y, Shimada M, Maehara Y. Ijichi H, et al. J Hepatol. 2006 Jul;45(1):28-34. doi: 10.1016/j.jhep.2005.12.021. Epub 2006 Feb 3. J Hepatol. 2006. PMID: 16513203

27

Biliary strictures in living donor liver transplantation: incidence, management, and technical evolution.

Soejima Y, Taketomi A, Yoshizumi T, Uchiyama H, Harada N, Ijichi H, Yonemura Y, Ikeda T, Shimada M, Maehara Y. Soejima Y, et al. Among authors: ijichi h. Liver Transpl. 2006 Jun;12(6):979-86. doi: 10.1002/lt.20740. Liver Transpl. 2006. PMID: 16721777 Free article.

28

Hepatic artery aneurysm arising from an interposition vein graft four years after auxiliary partial orthotopic liver transplantation.

Uchiyama H, Soejima Y, Taketomi A, Yoshizumi T, Harada N, Ijichi H, Yonemura Y, Maehara Y. Uchiyama H, et al. Among authors: ijichi h. Transpl Int. 2007 Feb;20(2):197-200. doi: 10.1111/j.1432-2277.2006.00402.x. Transpl Int. 2007. PMID: 17239030 Free article. No abstract available.

29

Successful management of chylous ascites after living donor liver transplantation with somatostatin.

Ijichi H, Soejima Y, Taketomi A, Yoshizumi T, Uchiyama H, Harada N, Yonemura Y, Maehara Y. Ijichi H, et al. Liver Int. 2008 Jan;28(1):143-5. doi: 10.1111/j.1478-3231.2007.01556.x. Liver Int. 2008. PMID: 18173563

30

Estimation of standard liver volume for Japanese adults.

Yoshizumi T, Taketomi A, Kayashima H, Yonemura Y, Harada N, Ijichi H, Soejima Y, Nishizaki T, Maehara Y. Yoshizumi T, et al. Among authors: ijichi h. Transplant Proc. 2008 Jun;40(5):1456-60. doi: 10.1016/j.transproceed.2008.02.082. Transplant Proc. 2008. PMID: 18589128

31

Accuracy of an age-adjusted formula in assessing the graft volume in living donor liver transplantation.

Kayashima H, Taketomi A, Yonemura Y, Ijichi H, Harada N, Yoshizumi T, Soejima Y, Yoshimitsu K, Maehara Y. Kayashima H, et al. Among authors: ijichi h. Liver Transpl. 2008 Sep;14(9):1366-71. doi: 10.1002/lt.21547. Liver Transpl. 2008. PMID: 18756495 Free article.

32

Tumor-infiltrating lymphocytes and hepatocellular carcinoma: pathology and clinical management.

Shirabe K, Motomura T, Muto J, Toshima T, Matono R, Mano Y, Takeishi K, Ijichi H, Harada N, Uchiyama H, Yoshizumi T, Taketomi A, Maehara Y. Shirabe K, et al. Among authors: ijichi h. Int J Clin Oncol. 2010 Dec;15(6):552-8. doi: 10.1007/s10147-010-0131-0. Epub 2010 Oct 21. Int J Clin Oncol. 2010. PMID: 20963618 Review.

33

Living donor liver transplantation in patients who have received pretransplant treatment for hepatocellular carcinoma.

Yoshizumi T, Shirabe K, Soejima Y, Taketomi A, Ikegami T, Uchiyama H, Harada N, Ijichi H, Maehara Y. Yoshizumi T, et al. Among authors: ijichi h. Transplantation. 2011 Apr 27;91(8):e61-2. doi: 10.1097/TP.0b013e318210de92. Transplantation. 2011. PMID: 21475066 No abstract available.

34

Pure laparoscopic right hepatectomy in the semi-prone position using the intrahepatic Glissonian approach and a modified hanging maneuver to minimize intraoperative bleeding.

Ikeda T, Yonemura Y, Ueda N, Kabashima A, Shirabe K, Taketomi A, Yoshizumi T, Uchiyama H, Harada N, Ijichi H, Kakeji Y, Morita M, Tsujitani S, Maehara Y. Ikeda T, et al. Among authors: ijichi h. Surg Today. 2011 Dec;41(12):1592-8. doi: 10.1007/s00595-010-4479-6. Epub 2011 Oct 4. Surg Today. 2011. PMID: 21969190

35

Granulocyte colony-stimulating-factor-producing hepatocellular carcinoma with extensive sarcomatous changes: report of a case.

Kohno M, Shirabe K, Mano Y, Muto J, Motomura T, Takeishi K, Toshima T, Yoshimatsu M, Ijichi H, Harada N, Aishima S, Uchiyama H, Yoshizumi T, Taketomi A, Maehara Y. Kohno M, et al. Among authors: ijichi h. Surg Today. 2013 Apr;43(4):439-45. doi: 10.1007/s00595-012-0202-0. Epub 2012 May 26. Surg Today. 2013. PMID: 22638568

36

Pancreatogastrostomy with an elastic purse-string suture around the gastric orifice after pancreatoduodenectomy.

Nishizaki T, Ijichi H, Terashi T, Shimabukuro R, Maruyama S, Guntani A, Yamaoka T, Inoue H, Shiraishi T, Wada H, Takahashi I. Nishizaki T, et al. Among authors: ijichi h. Surg Today. 2009;39(6):548-51. doi: 10.1007/s00595-008-3908-2. Epub 2009 May 27. Surg Today. 2009. PMID: 19468816

37

Coexistence of mucinous cystic neoplasm occurring in the head of the pancreas with annular pancreas: report of a case.

Ijichi H, Nishizaki T, Terashi T, Shiraishi T, Takahashi I, Wada H, Joko K, Yoshioka S, Murata S, Oshiro Y. Ijichi H, et al. Surg Today. 2009;39(10):897-900. doi: 10.1007/s00595-008-3956-7. Epub 2009 Sep 27. Surg Today. 2009. PMID: 19784731

38

Temporal changes in the stiffness of the remnant liver and spleen after donor hepatectomy as assessed by acoustic radiation force impulse: A preliminary study.

Ninomiya M, Shirabe K, Ijichi H, Toshima T, Harada N, Uchiyama H, Taketomi A, Yoshizumi T, Maehara Y. Ninomiya M, et al. Among authors: ijichi h. Hepatol Res. 2011 Jun;41(6):579-86. doi: 10.1111/j.1872-034X.2011.00809.x. Epub 2011 May 11. Hepatol Res. 2011. PMID: 21561532

39

Left lobe living donor liver transplantation in adults.

Soejima Y, Shirabe K, Taketomi A, Yoshizumi T, Uchiyama H, Ikegami T, Ninomiya M, Harada N, Ijichi H, Maehara Y. Soejima Y, et al. Among authors: ijichi h. Am J Transplant. 2012 Jul;12(7):1877-85. doi: 10.1111/j.1600-6143.2012.04022.x. Epub 2012 Mar 19. Am J Transplant. 2012. PMID: 22429497 Free article.

40

[Section staining technique for whole body autoradiographic studies of the mice].

Watanabe M, Shimada M, Kurimoto K, Maruyama Y, Ijichi H. Watanabe M, et al. Among authors: ijichi h. Kaibogaku Zasshi. 1975 Oct 1;50(5):250-7. Kaibogaku Zasshi. 1975. PMID: 53985 Japanese. No abstract available.

41

Contralateral occurrence after laparoscopic total extraperitoneal hernia repair for unilateral inguinal hernia.

Uchida H, Matsumoto T, Ijichi H, Endo Y, Koga T, Takeuchi H, Kusumoto T, Muto Y, Kitano S. Uchida H, et al. Among authors: ijichi h. Hernia. 2010 Oct;14(5):481-4. doi: 10.1007/s10029-010-0690-z. Epub 2010 Jun 11. Hernia. 2010. PMID: 20544367

42

Topographic separation of lyophilized mouse brain and gas-liquid chromatographic analysis of free amino acids in brain divisions.

Shimada M, Kihara T, Kurimoto K, Maruyama Y, Ijichi H. Shimada M, et al. Among authors: ijichi h. Kaibogaku Zasshi. 1972 Apr 1;47(2):138-53. Kaibogaku Zasshi. 1972. PMID: 5065471 No abstract available.

43

[A juvenile case of mesenchymal chondrosarcoma originating from soft tissue in the orbit].

Ijichi H, Ishikawa K, Hida T, Fujiwara T, Fukuzumi N, Yabe H. Ijichi H, et al. Nippon Ganka Gakkai Zasshi. 1992 Jun;96(6):805-12. Nippon Ganka Gakkai Zasshi. 1992. PMID: 1626483 Japanese.

44

[Scanning and transmission electron microscopic studies of the ultrastructure of the corneal endothelium in developing human eye].

Ijichi H, Hida T, Fukuda M, Azuma N. Ijichi H, et al. Nippon Ganka Gakkai Zasshi. 1992 Nov;96(11):1351-6. Nippon Ganka Gakkai Zasshi. 1992. PMID: 1476064 Japanese.

45

[Report of two cases with idiopathic true exfoliation of the lens capsule--histopathological and electron microscopical study].

Asakage H, Ijichi H, Ishiwata T, Hida T, Fujiwara T, Fukuda M. Asakage H, et al. Among authors: ijichi h. Nippon Ganka Gakkai Zasshi. 1994 Jul;98(7):664-71. Nippon Ganka Gakkai Zasshi. 1994. PMID: 8067300 Japanese.

46

Preoperative Neutrophil-to-Lymphocyte Ratio in Postmenopausal Breast Cancer Patients.

Ijichi H, Tajiri W, Koi Y, Koga C, Nakamura Y, Okamoto M, Tokunaga E. Ijichi H, et al. J Surg Res. 2024 Apr;296:98-105. doi: 10.1016/j.jss.2023.11.075. Epub 2024 Jan 23. J Surg Res. 2024. PMID: 38266423

47

The Effect of Renin-Angiotensin System Inhibitors in Patients Undergoing Pancreatic Cancer Resection.

Abe S, Nakai Y, Arita J, Ichida A, Kawaguchi Y, Akamatsu N, Kaneko J, Ijichi H, Koike K, Fujishiro M, Hasegawa K. Abe S, et al. Among authors: ijichi h. Pancreas. 2024 Mar 1;53(3):e233-e239. doi: 10.1097/MPA.0000000000002291. Epub 2024 Jan 15. Pancreas. 2024. PMID: 38227640

48

Effects of tramadol via a µ-opioid receptor on pancreatic ductal adenocarcinoma in vitro and in vivo.

Kuramochi T, Sano M, Kajiwara I, Oshima Y, Itaya T, Kim J, Ichimaru Y, Kitajima O, Masamune A, Ijichi H, Suzuki T. Kuramochi T, et al. Among authors: ijichi h. Reg Anesth Pain Med. 2024 Mar 4;49(3):200-208. doi: 10.1136/rapm-2023-104511. Reg Anesth Pain Med. 2024. PMID: 37353355

49

Significance of Tumor Microenvironment for Regulating Pancreatic Cancer.

Ijichi H. Ijichi H. Cancers (Basel). 2023 Apr 26;15(9):2482. doi: 10.3390/cancers15092482. Cancers (Basel). 2023. PMID: 37173948 Free PMC article.

50

Combination of serum human satellite RNA and miR-21-5p levels as a biomarker for pancreatic cancer.

Seimiya T, Suzuki T, Iwata T, Kishikawa T, Sekiba K, Shibata C, Ishigaki K, Fujiwara H, Oyama H, Kanai S, Sato T, Nakai Y, Ishibashi R, Moriyama M, Nakagawa R, Ijichi H, Otsuka M, Koike K. Seimiya T, et al. Among authors: ijichi h. iScience. 2023 Jan 19;26(2):106021. doi: 10.1016/j.isci.2023.106021. eCollection 2023 Feb 17. iScience. 2023. PMID: 36798431 Free PMC article.

51

Clinical Outcomes of Intraductal Papillary Mucinous Neoplasms With Dilatation of the Main Pancreatic Duct.

Hamada T, Oyama H, Nakai Y, Tange S, Arita J, Hakuta R, Ijichi H, Ishigaki K, Kanai S, Kawaguchi Y, Kogure H, Mizuno S, Saito K, Saito T, Sato T, Suzuki T, Takahara N, Tanaka M, Tateishi K, Ushiku T, Hasegawa K, Fujishiro M. Hamada T, et al. Among authors: ijichi h. Clin Gastroenterol Hepatol. 2023 Jul;21(7):1792-1801.e3. doi: 10.1016/j.cgh.2023.01.032. Epub 2023 Feb 12. Clin Gastroenterol Hepatol. 2023. PMID: 36787835

52

Virtual monochromatic spectral CT imaging in preoperative evaluations for intraductal spread of breast cancer: comparison with conventional CT and MRI.

Matsuura Y, Kamitani T, Sagiyama K, Yamasaki Y, Hino T, Kubo M, Ijichi H, Yamamoto H, Yabuuchi H, Ishigami K. Matsuura Y, et al. Among authors: ijichi h. Jpn J Radiol. 2023 Jul;41(7):733-740. doi: 10.1007/s11604-023-01392-4. Epub 2023 Feb 2. Jpn J Radiol. 2023. PMID: 36729189 Free PMC article.

53

Mirogabalin improves cancer-associated pain but increases the risk of malignancy in mice with pancreatic cancer.

Itaya T, Sano M, Kajiwara I, Oshima Y, Kuramochi T, Kim J, Ichimaru Y, Kitajima O, Masamune A, Ijichi H, Ishii Y, Suzuki T. Itaya T, et al. Among authors: ijichi h. Pain. 2023 Jul 1;164(7):1545-1554. doi: 10.1097/j.pain.0000000000002852. Epub 2022 Dec 20. Pain. 2023. PMID: 36701124

54

Overcoming resistance of stroma-rich pancreatic cancer with focal adhesion kinase inhibitor combined with G47Δ and immune checkpoint inhibitors.

Yamada T, Tateishi R, Iwai M, Tanaka M, Ijichi H, Sano M, Koike K, Todo T. Yamada T, et al. Among authors: ijichi h. Mol Ther Oncolytics. 2022 Dec 7;28:31-43. doi: 10.1016/j.omto.2022.12.001. eCollection 2023 Mar 16. Mol Ther Oncolytics. 2022. PMID: 36619294 Free PMC article.

55

[Comparative Safety Study of Original and Generic Docetaxel without Alcohol in the Treatment of Breast Cancer].

Hara M, Eto T, Ijichi H, Nakamura Y, Koga C, Tajiri W, Okamoto M, Tokunaga E, Misumi N. Hara M, et al. Among authors: ijichi h. Gan To Kagaku Ryoho. 2022 Dec;49(12):1355-1359. Gan To Kagaku Ryoho. 2022. PMID: 36539249 Japanese.

56

HNF1B-driven three-dimensional chromatin structure for molecular classification in pancreatic cancers.

Kato H, Tateishi K, Iwadate D, Yamamoto K, Fujiwara H, Nakatsuka T, Kudo Y, Hayakawa Y, Ijichi H, Otsuka M, Kishikawa T, Takahashi R, Miyabayashi K, Nakai Y, Hirata Y, Toyoda A, Morishita S, Fujishiro M. Kato H, et al. Among authors: ijichi h. Cancer Sci. 2023 Apr;114(4):1672-1685. doi: 10.1111/cas.15690. Epub 2022 Dec 25. Cancer Sci. 2023. PMID: 36511816 Free PMC article.

57

Multiphasic Heterogeneity of Fibroblasts in the Microenvironment of Pancreatic Ductal Adenocarcinoma: Dissection and the Sum of the Dynamics.

Ijichi H. Ijichi H. Cancers (Basel). 2022 Oct 5;14(19):4880. doi: 10.3390/cancers14194880. Cancers (Basel). 2022. PMID: 36230803 Free PMC article.

58

The Role of the Microbiome in Pancreatic Cancer.

Miyabayashi K, Ijichi H, Fujishiro M. Miyabayashi K, et al. Among authors: ijichi h. Cancers (Basel). 2022 Sep 15;14(18):4479. doi: 10.3390/cancers14184479. Cancers (Basel). 2022. PMID: 36139638 Free PMC article. Review.

59

The Role of Neural Signaling in the Pancreatic Cancer Microenvironment.

Takahashi R, Ijichi H, Fujishiro M. Takahashi R, et al. Among authors: ijichi h. Cancers (Basel). 2022 Aug 31;14(17):4269. doi: 10.3390/cancers14174269. Cancers (Basel). 2022. PMID: 36077804 Free PMC article. Review.

60

Midazolam exhibits antitumour and anti-inflammatory effects in a mouse model of pancreatic ductal adenocarcinoma.

Oshima Y, Sano M, Kajiwara I, Ichimaru Y, Itaya T, Kuramochi T, Hayashi E, Kim J, Kitajima O, Masugi Y, Masamune A, Ijichi H, Ishii Y, Suzuki T. Oshima Y, et al. Among authors: ijichi h. Br J Anaesth. 2022 Apr;128(4):679-690. doi: 10.1016/j.bja.2021.12.042. Epub 2022 Feb 2. Br J Anaesth. 2022. PMID: 35120712 Free article.

61

MNX1-HNF1B Axis Is Indispensable for Intraductal Papillary Mucinous Neoplasm Lineages.

Kato H, Tateishi K, Fujiwara H, Nakatsuka T, Yamamoto K, Kudo Y, Hayakawa Y, Nakagawa H, Tanaka Y, Ijichi H, Otsuka M, Iwadate D, Oyama H, Kanai S, Noguchi K, Suzuki T, Sato T, Hakuta R, Ishigaki K, Saito K, Saito T, Takahara N, Kishikawa T, Hamada T, Takahashi R, Miyabayashi K, Mizuno S, Kogure H, Nakai Y, Hirata Y, Toyoda A, Ichikawa K, Qu W, Morishita S, Arita J, Tanaka M, Ushiku T, Hasegawa K, Fujishiro M, Koike K. Kato H, et al. Among authors: ijichi h. Gastroenterology. 2022 Apr;162(4):1272-1287.e16. doi: 10.1053/j.gastro.2021.12.254. Epub 2021 Dec 22. Gastroenterology. 2022. PMID: 34953915

62

Protein intake after the initiation of chemotherapy is an independent prognostic factor for overall survival in patients with unresectable pancreatic cancer: A prospective cohort study.

Hasegawa Y, Ijichi H, Saito K, Ishigaki K, Takami M, Sekine R, Usami S, Nakai Y, Koike K, Kubota N. Hasegawa Y, et al. Among authors: ijichi h. Clin Nutr. 2021 Jul;40(7):4792-4798. doi: 10.1016/j.clnu.2021.06.011. Epub 2021 Jun 17. Clin Nutr. 2021. PMID: 34265503

63

ABO Blood Group and Risk of Pancreatic Carcinogenesis in Intraductal Papillary Mucinous Neoplasms.

Hamada T, Oyama H, Nakai Y, Tada M, Koh H, Tateishi K, Arita J, Hakuta R, Ijichi H, Ishigaki K, Kawaguchi Y, Kogure H, Mizuno S, Morikawa T, Saito K, Saito T, Sato T, Takagi K, Takahara N, Takahashi R, Tanaka A, Tanaka M, Ushiku T, Hasegawa K, Koike K. Hamada T, et al. Among authors: ijichi h. Cancer Epidemiol Biomarkers Prev. 2021 May;30(5):1020-1028. doi: 10.1158/1055-9965.EPI-20-1581. Epub 2021 Mar 2. Cancer Epidemiol Biomarkers Prev. 2021. PMID: 33653811

64

Inhibition of histone methyltransferase G9a attenuates liver cancer initiation by sensitizing DNA-damaged hepatocytes to p53-induced apoptosis.

Nakatsuka T, Tateishi K, Kato H, Fujiwara H, Yamamoto K, Kudo Y, Nakagawa H, Tanaka Y, Ijichi H, Ikenoue T, Ishizawa T, Hasegawa K, Tachibana M, Shinkai Y, Koike K. Nakatsuka T, et al. Among authors: ijichi h. Cell Death Dis. 2021 Jan 19;12(1):99. doi: 10.1038/s41419-020-03381-1. Cell Death Dis. 2021. PMID: 33468997 Free PMC article.

65

Soluble VCAM-1 promotes gemcitabine resistance via macrophage infiltration and predicts therapeutic response in pancreatic cancer.

Takahashi R, Ijichi H, Sano M, Miyabayashi K, Mohri D, Kim J, Kimura G, Nakatsuka T, Fujiwara H, Yamamoto K, Kudo Y, Tanaka Y, Tateishi K, Nakai Y, Morishita Y, Soma K, Takeda N, Moses HL, Isayama H, Koike K. Takahashi R, et al. Among authors: ijichi h. Sci Rep. 2020 Dec 3;10(1):21194. doi: 10.1038/s41598-020-78320-3. Sci Rep. 2020. PMID: 33273652 Free PMC article.

66

Inhibition of transforming growth factor-β signaling in myeloid cells ameliorates aortic aneurysmal formation in Marfan syndrome.

Hara H, Maemura S, Fujiwara T, Takeda N, Ishii S, Yagi H, Suzuki T, Harada M, Toko H, Kanaya T, Ijichi H, Moses HL, Takimoto E, Morita H, Akazawa H, Komuro I. Hara H, et al. Among authors: ijichi h. PLoS One. 2020 Nov 11;15(11):e0239908. doi: 10.1371/journal.pone.0239908. eCollection 2020. PLoS One. 2020. PMID: 33175881 Free PMC article.

67

Deletion of Histone Methyltransferase G9a Suppresses Mutant Kras-driven Pancreatic Carcinogenesis.

Kato H, Tateishi K, Fujiwara H, Ijichi H, Yamamoto K, Nakatsuka T, Kakiuchi M, Sano M, Kudo Y, Hayakawa Y, Nakagawa H, Tanaka Y, Otsuka M, Hirata Y, Tachibana M, Shinkai Y, Koike K. Kato H, et al. Among authors: ijichi h. Cancer Genomics Proteomics. 2020 Nov-Dec;17(6):695-705. doi: 10.21873/cgp.20224. Cancer Genomics Proteomics. 2020. PMID: 33099471 Free PMC article.

68

A retrospective comparative study of S-IROX and modified FOLFIRINOX for patients with advanced pancreatic cancer refractory to gemcitabine plus nab-paclitaxel.

Saito K, Nakai Y, Takahara N, Ishigaki K, Suzuki Y, Inokuma A, Noguchi K, Kanai S, Sato T, Hakuta R, Saito T, Hamada T, Mizuno S, Kogure H, Ijichi H, Tateishi K, Koike K. Saito K, et al. Among authors: ijichi h. Invest New Drugs. 2021 Apr;39(2):605-613. doi: 10.1007/s10637-020-01022-0. Epub 2020 Oct 23. Invest New Drugs. 2021. PMID: 33094362

69

Blocking VCAM-1 inhibits pancreatic tumour progression and cancer-associated thrombosis/thromboembolism.

Sano M, Takahashi R, Ijichi H, Ishigaki K, Yamada T, Miyabayashi K, Kimura G, Mizuno S, Kato H, Fujiwara H, Nakatsuka T, Tanaka Y, Kim J, Masugi Y, Morishita Y, Tanaka M, Ushiku T, Nakai Y, Tateishi K, Ishii Y, Isayama H, Moses HL, Koike K. Sano M, et al. Among authors: ijichi h. Gut. 2021 Sep;70(9):1713-1723. doi: 10.1136/gutjnl-2020-320608. Epub 2020 Oct 21. Gut. 2021. PMID: 33087490

70

Duloxetine improves cancer-associated pain in a mouse model of pancreatic cancer through stimulation of noradrenaline pathway and its antitumor effects.

Kajiwara I, Sano M, Ichimaru Y, Oshima Y, Kitajima O, Hao H, Masamune A, Kim J, Ishii Y, Ijichi H, Suzuki T. Kajiwara I, et al. Among authors: ijichi h. Pain. 2020 Dec;161(12):2909-2919. doi: 10.1097/j.pain.0000000000001997. Pain. 2020. PMID: 32694385

71

Mutant IDH1 confers resistance to energy stress in normal biliary cells through PFKP-induced aerobic glycolysis and AMPK activation.

Fujiwara H, Tateishi K, Misumi K, Hayashi A, Igarashi K, Kato H, Nakatsuka T, Suzuki N, Yamamoto K, Kudo Y, Hayakawa Y, Nakagawa H, Tanaka Y, Ijichi H, Kogure H, Nakai Y, Isayama H, Hasegawa K, Fukayama M, Soga T, Koike K. Fujiwara H, et al. Among authors: ijichi h. Sci Rep. 2019 Dec 11;9(1):18859. doi: 10.1038/s41598-019-55211-w. Sci Rep. 2019. PMID: 31827136 Free PMC article.

72

Late-Evening Carbohydrate and Branched-Chain Amino Acid Snacks Improve the Nutritional Status of Patients Undergoing Hepatectomy Based on Bioelectrical Impedance Analysis of Body Composition.

Kobayashi K, Kaneko J, Yamaguchi T, Kawaguchi Y, Arita J, Akamatsu N, Ishizawa T, Sekine R, Ijichi H, Kubota N, Fukatsu K, Kokudo N, Hasegawa K. Kobayashi K, et al. Among authors: ijichi h. Gastrointest Tumors. 2019 Oct;6(3-4):81-91. doi: 10.1159/000501452. Epub 2019 Aug 29. Gastrointest Tumors. 2019. PMID: 31768352 Free PMC article.

73

Indirubin 3'-Oxime Inhibits Migration, Invasion, and Metastasis InVivo in Mice Bearing Spontaneously Occurring Pancreatic Cancer via Blocking the RAF/ERK, AKT, and SAPK/JNK Pathways.

Ichimaru Y, Sano M, Kajiwara I, Tobe T, Yoshioka H, Hayashi K, Ijichi H, Miyairi S. Ichimaru Y, et al. Among authors: ijichi h. Transl Oncol. 2019 Dec;12(12):1574-1582. doi: 10.1016/j.tranon.2019.08.010. Epub 2019 Oct 28. Transl Oncol. 2019. PMID: 31671317 Free PMC article.

74

Long-term Risk of Malignancy in Branch-Duct Intraductal Papillary Mucinous Neoplasms.

Oyama H, Tada M, Takagi K, Tateishi K, Hamada T, Nakai Y, Hakuta R, Ijichi H, Ishigaki K, Kanai S, Kogure H, Mizuno S, Saito K, Saito T, Sato T, Suzuki T, Takahara N, Morishita Y, Arita J, Hasegawa K, Tanaka M, Fukayama M, Koike K. Oyama H, et al. Among authors: ijichi h. Gastroenterology. 2020 Jan;158(1):226-237.e5. doi: 10.1053/j.gastro.2019.08.032. Epub 2019 Aug 29. Gastroenterology. 2020. PMID: 31473224

75

Diagnostic yield of the plasma free amino acid index for pancreatic cancer in patients with diabetes mellitus.

Mizuno S, Isayama H, Nakai Y, Ishigaki K, Saito K, Sato T, Takeda T, Hakuta R, Saito T, Takahara N, Kogure H, Ijichi H, Tateishi K, Tada M, Shikata N, Tagami T, Kikuchi S, Yamamoto H, Yamakado M, Koike K. Mizuno S, et al. Among authors: ijichi h. Pancreatology. 2019 Jul;19(5):695-698. doi: 10.1016/j.pan.2019.07.002. Epub 2019 Jul 13. Pancreatology. 2019. PMID: 31320196

76

Blocking CXCLs-CXCR2 axis in tumor-stromal interactions contributes to survival in a mouse model of pancreatic ductal adenocarcinoma through reduced cell invasion/migration and a shift of immune-inflammatory microenvironment.

Sano M, Ijichi H, Takahashi R, Miyabayashi K, Fujiwara H, Yamada T, Kato H, Nakatsuka T, Tanaka Y, Tateishi K, Morishita Y, Moses HL, Isayama H, Koike K. Sano M, et al. Among authors: ijichi h. Oncogenesis. 2019 Jan 18;8(2):8. doi: 10.1038/s41389-018-0117-8. Oncogenesis. 2019. PMID: 30659170 Free PMC article.

77

Effect of home enteral nutrition after pancreaticoduodenectomy.

Ito D, Arita J, Yamamoto M, Akamatsu N, Kaneko J, Ijichi H, Kubota N, Sakamoto Y, Kokudo N, Hasegawa K. Ito D, et al. Among authors: ijichi h. Nutrition. 2019 Apr;60:206-211. doi: 10.1016/j.nut.2018.10.007. Epub 2018 Oct 10. Nutrition. 2019. PMID: 30616102

78

A phase II trial of gemcitabine, S-1 and LV combination (GSL) therapy in patients with advanced pancreatic cancer.

Saito K, Isayama H, Nakai Y, Takahara N, Ishigaki K, Takeda T, Hakuta R, Saito T, Uchino R, Kishikawa T, Hamada T, Mizuno S, Sasaki T, Kogure H, Matsubara S, Yamamoto N, Ijichi H, Tateishi K, Tada M, Koike K. Saito K, et al. Among authors: ijichi h. Invest New Drugs. 2019 Apr;37(2):338-344. doi: 10.1007/s10637-018-0691-9. Epub 2018 Nov 9. Invest New Drugs. 2019. PMID: 30411217 Clinical Trial.

79

Isocitrate dehydrogenase 1 mutation sensitizes intrahepatic cholangiocarcinoma to the BET inhibitor JQ1.

Fujiwara H, Tateishi K, Kato H, Nakatsuka T, Yamamoto K, Tanaka Y, Ijichi H, Takahara N, Mizuno S, Kogure H, Matsubara S, Nakai Y, Koike K. Fujiwara H, et al. Among authors: ijichi h. Cancer Sci. 2018 Nov;109(11):3602-3610. doi: 10.1111/cas.13784. Epub 2018 Sep 17. Cancer Sci. 2018. PMID: 30156013 Free PMC article.

80

Adhesive Interactions between Mononuclear Phagocytes and Intestinal Epithelium Perturb Normal Epithelial Differentiation and Serve as a Therapeutic Target in Inflammatory Bowel Disease.

Ihara S, Hirata Y, Hikiba Y, Yamashita A, Tsuboi M, Hata M, Konishi M, Suzuki N, Sakitani K, Kinoshita H, Hayakawa Y, Nakagawa H, Ijichi H, Tateishi K, Koike K. Ihara S, et al. Among authors: ijichi h. J Crohns Colitis. 2018 Nov 9;12(10):1219-1231. doi: 10.1093/ecco-jcc/jjy088. J Crohns Colitis. 2018. PMID: 29917067

81

A phase II trial of gemcitabine, S-1 and LV combination (GSL) neoadjuvant chemotherapy for patients with borderline resectable and locally advanced pancreatic cancer.

Saito K, Isayama H, Sakamoto Y, Nakai Y, Ishigaki K, Tanaka M, Watadani T, Arita J, Takahara N, Mizuno S, Kogure H, Ijichi H, Tateishi K, Tada M, Hasegawa K, Fukayama M, Kokudo N, Koike K. Saito K, et al. Among authors: ijichi h. Med Oncol. 2018 May 30;35(7):100. doi: 10.1007/s12032-018-1158-8. Med Oncol. 2018. PMID: 29846849 Clinical Trial.

82

Overexpression of HER2 in the pancreas promotes development of intraductal papillary mucinous neoplasms in mice.

Shibata W, Kinoshita H, Hikiba Y, Sato T, Ishii Y, Sue S, Sugimori M, Suzuki N, Sakitani K, Ijichi H, Mori R, Endo I, Maeda S. Shibata W, et al. Among authors: ijichi h. Sci Rep. 2018 Apr 18;8(1):6150. doi: 10.1038/s41598-018-24375-2. Sci Rep. 2018. PMID: 29670173 Free PMC article.

83

Impact of histone demethylase KDM3A-dependent AP-1 transactivity on hepatotumorigenesis induced by PI3K activation.

Nakatsuka T, Tateishi K, Kudo Y, Yamamoto K, Nakagawa H, Fujiwara H, Takahashi R, Miyabayashi K, Asaoka Y, Tanaka Y, Ijichi H, Hirata Y, Otsuka M, Kato M, Sakai J, Tachibana M, Aburatani H, Shinkai Y, Koike K. Nakatsuka T, et al. Among authors: ijichi h. Oncogene. 2017 Nov 9;36(45):6262-6271. doi: 10.1038/onc.2017.222. Epub 2017 Jul 10. Oncogene. 2017. PMID: 28692045

84

Prevalence of Pancreatic Cystic Lesions Is Associated With Diabetes Mellitus and Obesity: An Analysis of 5296 Individuals Who Underwent a Preventive Medical Examination.

Mizuno S, Isayama H, Nakai Y, Yoshikawa T, Ishigaki K, Matsubara S, Yamamoto N, Ijichi H, Tateishi K, Tada M, Hayashi N, Koike K. Mizuno S, et al. Among authors: ijichi h. Pancreas. 2017 Jul;46(6):801-805. doi: 10.1097/MPA.0000000000000833. Pancreas. 2017. PMID: 28609369

85

Biliary epithelial injury-induced regenerative response by IL-33 promotes cholangiocarcinogenesis from peribiliary glands.

Nakagawa H, Suzuki N, Hirata Y, Hikiba Y, Hayakawa Y, Kinoshita H, Ihara S, Uchino K, Nishikawa Y, Ijichi H, Otsuka M, Arita J, Sakamoto Y, Hasegawa K, Kokudo N, Tateishi K, Koike K. Nakagawa H, et al. Among authors: ijichi h. Proc Natl Acad Sci U S A. 2017 May 9;114(19):E3806-E3815. doi: 10.1073/pnas.1619416114. Epub 2017 Apr 24. Proc Natl Acad Sci U S A. 2017. PMID: 28439013 Free PMC article.

86

Corrigendum: A novel mouse model of intrahepatic cholangiocarcinoma induced by liver-specific Kras activation and Pten deletion.

Ikenoue T, Terakado Y, Nakagawa H, Hikiba Y, Fujii T, Matsubara D, Noguchi R, Zhu C, Yamamoto K, Kudo Y, Asaoka Y, Yamaguchi K, Ijichi H, Tateishi K, Fukushima N, Maeda S, Koike K, Furukawa Y. Ikenoue T, et al. Among authors: ijichi h. Sci Rep. 2017 Jan 3;7:39567. doi: 10.1038/srep39567. Sci Rep. 2017. PMID: 28045050 Free PMC article. No abstract available.

87

Sharpin promotes hepatocellular carcinoma progression via transactivation of Versican expression.

Tanaka Y, Tateishi K, Nakatsuka T, Kudo Y, Takahashi R, Miyabayashi K, Yamamoto K, Asaoka Y, Ijichi H, Tateishi R, Shibahara J, Fukayama M, Ishizawa T, Hasegawa K, Kokudo N, Koike K. Tanaka Y, et al. Among authors: ijichi h. Oncogenesis. 2016 Dec 12;5(12):e277. doi: 10.1038/oncsis.2016.76. Oncogenesis. 2016. PMID: 27941932 Free PMC article.

88

Satellite RNAs promote pancreatic oncogenic processes via the dysfunction of YBX1.

Kishikawa T, Otsuka M, Yoshikawa T, Ohno M, Ijichi H, Koike K. Kishikawa T, et al. Among authors: ijichi h. Nat Commun. 2016 Sep 26;7:13006. doi: 10.1038/ncomms13006. Nat Commun. 2016. PMID: 27667193 Free PMC article.

89

No Survival Benefit from the Inhibition of Renin-Angiotensin System in Biliary Tract Cancer.

Nakai Y, Isayama H, Sasaki T, Takahara N, Saito K, Takeda T, Umefune G, Saito T, Takagi K, Watanabe T, Hamada T, Uchino R, Mizuno S, Yamamoto K, Kogure H, Matsubara S, Yamamoto N, Ijichi H, Tateishi K, Tada M, Koike K. Nakai Y, et al. Among authors: ijichi h. Anticancer Res. 2016 Sep;36(9):4965-70. doi: 10.21873/anticanres.11065. Anticancer Res. 2016. PMID: 27630357

90

Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer.

Yamamoto K, Tateishi K, Kudo Y, Hoshikawa M, Tanaka M, Nakatsuka T, Fujiwara H, Miyabayashi K, Takahashi R, Tanaka Y, Ijichi H, Nakai Y, Isayama H, Morishita Y, Aoki T, Sakamoto Y, Hasegawa K, Kokudo N, Fukayama M, Koike K. Yamamoto K, et al. Among authors: ijichi h. Oncotarget. 2016 Sep 20;7(38):61469-61484. doi: 10.18632/oncotarget.11129. Oncotarget. 2016. PMID: 27528027 Free PMC article.

91

TGF-β Signaling in Dendritic Cells Governs Colonic Homeostasis by Controlling Epithelial Differentiation and the Luminal Microbiota.

Ihara S, Hirata Y, Serizawa T, Suzuki N, Sakitani K, Kinoshita H, Hayakawa Y, Nakagawa H, Ijichi H, Tateishi K, Koike K. Ihara S, et al. Among authors: ijichi h. J Immunol. 2016 Jun 1;196(11):4603-13. doi: 10.4049/jimmunol.1502548. Epub 2016 Apr 22. J Immunol. 2016. PMID: 27183608

92

A novel mouse model of intrahepatic cholangiocarcinoma induced by liver-specific Kras activation and Pten deletion.

Ikenoue T, Terakado Y, Nakagawa H, Hikiba Y, Fujii T, Matsubara D, Noguchi R, Zhu C, Yamamoto K, Kudo Y, Asaoka Y, Yamaguchi K, Ijichi H, Tateishi K, Fukushima N, Maeda S, Koike K, Furukawa Y. Ikenoue T, et al. Among authors: ijichi h. Sci Rep. 2016 Apr 1;6:23899. doi: 10.1038/srep23899. Sci Rep. 2016. PMID: 27032374 Free PMC article.

93

A potent therapeutics for gallbladder cancer by combinatorial inhibition of the MAPK and mTOR signaling networks.

Mohri D, Ijichi H, Miyabayashi K, Takahashi R, Kudo Y, Sasaki T, Asaoka Y, Tanaka Y, Ikenoue T, Tateishi K, Tada M, Isayama H, Koike K. Mohri D, et al. Among authors: ijichi h. J Gastroenterol. 2016 Jul;51(7):711-21. doi: 10.1007/s00535-015-1145-1. Epub 2015 Nov 27. J Gastroenterol. 2016. PMID: 26614007

94

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.

Asaoka Y, Ijichi H, Koike K. Asaoka Y, et al. Among authors: ijichi h. N Engl J Med. 2015 Nov 12;373(20):1979. doi: 10.1056/NEJMc1510353. N Engl J Med. 2015. PMID: 26559583 No abstract available.

95

[IPMN and pancreatic cyst as high risk of pancreatic cancer].

Tada M, Takagi K, Kawakubo K, Hakuta R, Ishigaki K, Takeda T, Fujiwara H, Umefune G, Saito K, Saito T, Watanabe T, Akiyama D, Uchino R, Kishikawa T, Takahara N, Takahashi R, Yamamoto K, Hamada T, Mizuno S, Miyabayashi K, Mohri D, Matsubara S, Kogure H, Nakai Y, Yamamoto N, Sasaki T, Sasahira N, Hirano K, Ijichi H, Tateishi K, Isayama H, Koike K. Tada M, et al. Among authors: ijichi h. Nihon Shokakibyo Gakkai Zasshi. 2015 Aug;112(8):1474-8. doi: 10.11405/nisshoshi.112.1474. Nihon Shokakibyo Gakkai Zasshi. 2015. PMID: 26250126 Japanese. No abstract available.

96

[Animal model of pancreatic cancer].

Ijichi H. Ijichi H. Nihon Rinsho. 2015 Mar;73 Suppl 3:31-6. Nihon Rinsho. 2015. PMID: 25856981 Japanese. No abstract available.

97

Pancreatic cancer with malignant ascites: clinical features and outcomes.

Takahara N, Isayama H, Nakai Y, Sasaki T, Saito K, Hamada T, Mizuno S, Miyabayashi K, Mohri D, Kogure H, Matsubara S, Yamamoto N, Hirano K, Ijichi H, Tateishi K, Tada M, Koike K. Takahara N, et al. Among authors: ijichi h. Pancreas. 2015 Apr;44(3):380-5. doi: 10.1097/MPA.0000000000000290. Pancreas. 2015. PMID: 25636085

98

The inhibition of renin-angiotensin system in advanced pancreatic cancer: an exploratory analysis in 349 patients.

Nakai Y, Isayama H, Sasaki T, Takahara N, Saito K, Ishigaki K, Hamada T, Mizuno S, Miyabayashi K, Yamamoto K, Mohri D, Kogure H, Yamamoto N, Ijichi H, Tateishi K, Tada M, Koike K. Nakai Y, et al. Among authors: ijichi h. J Cancer Res Clin Oncol. 2015 May;141(5):933-9. doi: 10.1007/s00432-014-1873-2. Epub 2014 Nov 15. J Cancer Res Clin Oncol. 2015. PMID: 25398651

99

Photoacoustic tomography of human hepatic malignancies using intraoperative indocyanine green fluorescence imaging.

Miyata A, Ishizawa T, Kamiya M, Shimizu A, Kaneko J, Ijichi H, Shibahara J, Fukayama M, Midorikawa Y, Urano Y, Kokudo N. Miyata A, et al. Among authors: ijichi h. PLoS One. 2014 Nov 7;9(11):e112667. doi: 10.1371/journal.pone.0112667. eCollection 2014. PLoS One. 2014. PMID: 25379674 Free PMC article.

100

A phase I trial of gemcitabine, S-1 and LV combination (GSL) therapy in advanced pancreatic cancer.

Nakai Y, Isayama H, Saito K, Sasaki T, Takahara N, Hamada T, Mizuno S, Miyabayashi K, Yamamoto K, Mohri D, Kogure H, Yamamoto N, Hirano K, Ijichi H, Tateishi K, Tada M, Koike K. Nakai Y, et al. Among authors: ijichi h. Cancer Chemother Pharmacol. 2014 Nov;74(5):911-5. doi: 10.1007/s00280-014-2563-0. Epub 2014 Aug 21. Cancer Chemother Pharmacol. 2014. PMID: 25143299 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

350 results

Search Page